Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis
- 1 April 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 33 (4) , 792-796
- https://doi.org/10.1097/01.ccm.0000159089.16462.4a
Abstract
To describe the course of plasma sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin (PCT), and C-reactive protein (CRP) concentrations during sepsis and their clinical informative value in predicting outcome. Prospective, noninterventional study. Medical adult intensive care unit at a university hospital in France. Sixty-three critically ill patients with sepsis, severe sepsis, or septic shock. None. Soluble TREM-1 concentrations were significantly lower at admission in nonsurvivors (n = 21) than in survivors (n = 42) (94 [30–258] vs. 154 [52–435] pg/mL, p = .02), whereas PCT levels were higher among nonsurvivors (19.2 [0.3–179] vs. 2.4 (0–254) pg/mL, p = .001). CRP levels did not differ between the two groups of patients. Plasma PCT and CRP decreased during the 14-day period of study in both survivors and nonsurvivors. Conversely, sTREM-1 plasma concentrations remained stable or even increased in nonsurviving patients and decreased in survivors. An elevated baseline sTREM-1 level was found to be an independent protective factor with an odds of dying of 0.1 (95% confidence interval, 0.1–0.8). A progressive decline of plasma sTREM-1 concentration indicates a favorable clinical evolution during the recovery phase of sepsis. In addition, baseline sTREM-1 level may prove useful in predicting outcome of septic patients.Keywords
This publication has 21 references indexed in Scilit:
- Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected SepsisAnnals of Internal Medicine, 2004
- Diagnostic and prognostic value of procalcitonin in patients with septic shockCritical Care Medicine, 2004
- Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of PneumoniaNew England Journal of Medicine, 2004
- TREM‐1 (Triggering Receptor Expressed on Myeloid Cells): A New Player in Acute Inflammatory ResponsesThe Journal of Infectious Diseases, 2003
- Comparison of procalcitonin and C-reactive protein as markers of sepsisCritical Care Medicine, 2003
- Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsisIntensive Care Medicine, 2002
- Plasma procalcitonin and C-reactive protein in acute septic shock: Clinical and biological correlatesCritical Care Medicine, 2002
- Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- TREM-1 amplifies inflammation and is a crucial mediator of septic shockNature, 2001
- Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and MonocytesThe Journal of Immunology, 2000